Medicaid Covered Outpatient Drugs Policy– Affordable Care Act

On January 21, 2016 the Centers for Medicare & Medicaid Services (CMS) issued the Covered Outpatient Drugs final rule with comment that addresses key areas of Medicaid drug reimbursement and changes made to the Medicaid Drug Rebate Program by the Affordable Care Act. This final rule also requests additional comments on the definition of line extension, which has a 60 day public comment period which will end on April 1, 2016. View the Fact Sheet to learn how this final rule assists states and the federal government in managing drug costs, establishing the long term framework for implementation of the Medicaid drug rebate program, and creating a more fair reimbursement system for Medicaid programs and pharmacies.

 

For additional information regarding Medicaid Covered Outpatient Drugs Policy

click on the link below:

 

https://www.medicaid.gov/medicaid-chip-program-information/by-topics/benefits/prescription-drugs/covered-outpatient-drugs-policy.html